Fundraising

B Capital Group closes fund at $360 mln

B Capital Group, a venture firm focused on healthcare, fintech, industrial logistics and consumer enablement companies, has raised $360 million for its new fund. Ropes & Gray LLP provided legal counsel on the fund. B Capital Group was founded in partnership with The Boston Consulting Group.

SWaN & Legend Venture Partners to raise $250 mln fourth venture fund

SWaN & Legend Venture Partners has set out to raise a $250 million fourth venture capital fund, according to a filing with the SEC.

New York accelerator Quake Capital unveils third class

New York accelerator and seed investor Quake Capital unveiled its third class of startups.

Danhua Capital racks up $343.2 mln for sophomore fund

Danhua Capital has raised $343.2 million for its second fund, according to an SEC filing. The Palo Alto, California-based venture firm invests mostly in early-stage tech companies.

TribalScale launches $100 mln venture-studio program

TribalScale, a creator of digital product strategy, design, and development, has launched TribalScale Venture Studios, a $100 million, five-year program that will connect entrepreneurs with Fortune 500 companies to launch industry-specific startups. The program will focus on four sectors: financial services, automotive, media and travel and hospitality. TribalScale has offices in Toronto, New York City, San Francisco, Dubai and Irvine, California.

Notation Capital launches its second fund with a focus on transparency

TrueBridge Capital Partners raises $450 mln for fifth venture fund-of-funds

TrueBridge Capital Partners has closed its fifth venture capital fund-of-funds at a hard cap of $450 million, beating its $375 million target. TrueBridge Fund V's limited partners include foundations and endowments, corporate and public pension funds, family offices and high-net-worth individuals.

TLV Partners raises $152.3 mln for second venture fund

TLV Partners has raised $152.3 million for a second venture capital fund, according to a filing with the SEC.

Can an ICO replace early-stage VC? 500 Startups alums hope so

Edmond De Rothschild Investment Partners wraps up biotech and medical device fund at $430 mln

Edmond De Rothschild Investment Partners has closed its fifth European biotech and medical device venture fund at 345 million euros ($430 million). The fund beat its initial target of 250 million euros.